ALISO VIEJO, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a Chief Financial Officer transition plan that calls for veteran financial executive Michael R. Rodriguez to become its Senior Vice President and Chief Financial Officer on December 7, 2009. Raymond J. Land, age 64, the current Senior Vice President and Chief Financial Officer of Clarient, will continue to serve in that position until Mr. Rodriguez takes over Mr. Land's duties, after which Mr. Land will remain with Clarient as a consultant until the final fiscal 2009 accounting is completed and Clarient's Form 10-K is filed with the Securities and Exchange Commission.
Mr. Rodriguez, age 42, has served as a senior financial executive in a variety of emerging growth companies, including two publicly-traded companies. His most recent experience was as Chief Financial Officer of Irvine, CA-based Endocare, a medical device company focused on minimally invasive technologies for tissue and tumor ablation, from 2004 through July 2009, when it was acquired by HealthTronics, Inc. He has extensive experience in strategic partnering and mergers and acquisitions, and is well-respected by the investment community.
"Michael is an accomplished CFO with a very strong background in financial leadership in public companies," said Clarient Vice Chairman and CEO Ron Andrews. "He has expertise in cancer diagnostics and medical technologies and a proven track record working in complex businesses creating the financial foundations critical to fast-growing, successful companies. He brings a strong focus on strategic planning and execution, and the critical technical and managerial experience we need in our finance department. We welcome
|SOURCE Clarient, Inc.|
Copyright©2009 PR Newswire.
All rights reserved